Osaic Holdings
COLL icon

Osaic Holdings’s Collegium Pharmaceutical COLL Stock Holding History

Osaic Holdings’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$363K Sell
10,034
-495
-5% -$16.9K ﹤0.01% 3945
2026
Q1 		$348K Sell
10,529
-26,497
-72% -$1.12M ﹤0.01% 3689
2025
Q4 		$1.71M Buy
37,026
+36,550
+7,679% +$1.53M ﹤0.01% 2211
2025
Q3 		$17.3K Sell
476
-74
-13% -$2.57K ﹤0.01% 6028
2025
Q2 		$16.3K Sell
550
-16
-3% -$456 ﹤0.01% 5854
2025
Q1 		$16.9K Buy
566
+495
+697% +$15.1K ﹤0.01% 5466
2024
Q4 		$2.03K Sell
71
-9,492
-99% -$314K ﹤0.01% 6595
2024
Q3 		$369K Sell
9,563
-146
-2% -$5.21K ﹤0.01% 3151
2024
Q2 		$313K Sell
9,709
-3,577
-27% -$124K ﹤0.01% 3175
2024
Q1 		$516K Buy
13,286
+12,435
+1,461% +$435K ﹤0.01% 2909
2023
Q4 		$25.9K Sell
851
-119
-12% -$2.98K ﹤0.01% 5346
2023
Q3 		$21.7K Buy
970
+93
+11% +$2.12K ﹤0.01% 5510
2023
Q2 		$18.8K Sell
877
-8,874
-91% -$201K ﹤0.01% 5603
2023
Q1 		$234K Buy
9,751
+3,652
+60% +$96.8K ﹤0.01% 3739
2022
Q4 		$142K Buy
6,099
+253
+4% +$5.1K ﹤0.01% 4138
2022
Q3 		$93K Buy
5,846
+5,035
+621% +$88.8K ﹤0.01% 4438
2022
Q2 		$14K Hold
811
– – ﹤0.01% 5843
2022
Q1 		$16K Buy
811
+120
+17% +$2.27K ﹤0.01% 5832
2021
Q4 		$12K Sell
691
-348
-33% -$6.78K ﹤0.01% 6129
2021
Q3 		$20K Sell
1,039
-110
-10% -$2.38K ﹤0.01% 5764
2021
Q2 		$27K Buy
1,149
+77
+7% +$1.78K ﹤0.01% 5463
2021
Q1 		$25K Sell
1,072
-469
-30% -$11.1K ﹤0.01% 5326
2020
Q4 		$30K Buy
1,541
+402
+35% +$7.85K ﹤0.01% 4912
2020
Q3 		$23K Sell
1,139
-256
-18% -$4.62K ﹤0.01% 4836
2020
Q2 		$25K Buy
1,395
+713
+105% +$14K ﹤0.01% 4657
2020
Q1 		$11K Buy
+682
New +$14.1K ﹤0.01% 4941

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Osaic Holdings's COLL Position: Q2 2026 in Review

Osaic Holdings reduced its Collegium Pharmaceutical (COLL) stake by 4.7% in Q2 2026, selling an estimated $16.9K and leaving 10,034 shares worth $363K. The position accounts for ﹤0.01% of the portfolio, ranked #3945.

Osaic Holdings first reported a position in COLL in Q1 2020 and has held it in 26 quarters since. The position peaked at $1.71M in Q4 2025. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • Osaic Holdings held 10,034 shares of Collegium Pharmaceutical worth $363K as of Q2 2026.
  • Osaic Holdings sold 495 Collegium Pharmaceutical shares in Q2 2026, an estimated $16.9K.
  • Collegium Pharmaceutical made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #3945 holding.
  • Osaic Holdings first reported a position in Collegium Pharmaceutical in Q1 2020 and has held it in 26 quarters since.
  • Osaic Holdings's Collegium Pharmaceutical position peaked at $1.71M in Q4 2025.
  • 279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.